Mycospor

Known as: Canesten brand of bifonazole 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2000
0246819832000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Moccasin-type tinea pedis(MTTP) is a hardly curable superficial dermatomycosis primarily characterized by hyperkeratosis of the… (More)
Is this relevant?
1996
1996
The usefulness of bifonazole (Mycospor), a topical imidazole antifungal agent approved 10 years ago, was evaluated for the… (More)
Is this relevant?
1984
1984
12 patients with tinea palmaris were treated with Mycospor (Bifonazole); the average persistence of disease was 10.5 years and… (More)
Is this relevant?
1984
1984
The morphological changes in the growing hyphae of Trichophyton mentagrophytes treated with a new azole antimycotic bifonazole… (More)
Is this relevant?
1983
1983
The new imadozolyl derivative 1-(p, alpha-diphenyl-benzyl)imidazole (bifonazole, Bay h 4502, Mycospor) shows in vitro the broad… (More)
Is this relevant?
1983
1983
1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole (bifonazole, Bay h 4502, Mycospor) preferentially inhibited yeast-hypha conversion… (More)
Is this relevant?
1983
1983
1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole (bifonazole, Bay h 4502, Mycospor) showed in vitro significant inhibitory activity… (More)
Is this relevant?
1983
1983
The in vitro activity of 1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole bifonazole, Bay h 4502, Mycospor) a new antifungal… (More)
Is this relevant?
1983
1983
The effect of a new azole antimycotic, 1-[(4-biphenylyl)-phenylmethyl]-1H-imidazole (bifonazole, Bay h 4502, Mycospor) on the… (More)
Is this relevant?
1983
1983
[14C]Bifonazole (1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole, Bay h 4502, Mycospor) was administered systemically (i.v.) and… (More)
Is this relevant?